Have a personal or library account? Click to login
Epidemiological insights into carbapenem resistant infections in critical care settings: A molecular and clinical investigation Cover

Epidemiological insights into carbapenem resistant infections in critical care settings: A molecular and clinical investigation

Open Access
|Oct 2025

References

  1. Medina E, Pieper DH. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Curr Top Microbiol Immunol 2016;398:3–33. DOI: 10.1007/82_2016_492.
  2. Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet 2024;404:1199–226. DOI: 10.1016/S0140-6736(24)01867-1.
  3. Antimicrobial resistance n.d. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed June 30, 2025).
  4. Bhattacharya S. Is screening patients for antibiotic-resistant bacteria justified in the Indian context? Indian J Med Microbiol 2011;29:213–7. DOI: 10.4103/0255-0857.83902.
  5. Rice LB. Controlling antibiotic resistance in the ICU: different bacteria, different strategies. Cleve Clin J Med 2003;70:793–800. DOI: 10.3949/ccjm.70.9.793.
  6. Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt C-E, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 2022;70:103227. DOI: 10.1016/j.iccn.2022.103227.
  7. Seifi K, Kazemian H, Heidari H, Rezagholizadeh F, Saee Y, Shirvani F, et al. Evaluation of Biofilm Formation Among Klebsiella pneumoniae Isolates and Molecular Characterization by ERIC-PCR. Jundishapur J Microbiol 2016;9:e30682. DOI: 10.5812/jjm.30682.
  8. eucast: Previous versions of documents n.d. https://www.eucast.org/ast_of_bacteria/previous_versions_of_documents (accessed July 31, 2025).
  9. Chatelut M, Dournes JL, Chabanon G, Marty N. Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR. J Clin Microbiol 1995;33:912–4. DOI: 10.1128/jcm.33.4.912-914.1995.
  10. Bar Ilan M, Kjerulf A. Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review. J Hosp Infect 2023;142:74–87. DOI: 10.1016/j.jhin.2023.09.018.
  11. Abramowicz L, Gerard M, Martiny D, Delforge M, De Wit S, Konopnicki D. Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome. Médecine Mal Infect 2020;50:658–64. DOI: 10.1016/j.medmal.2019.12.011.
  12. Räisänen K, Lyytikäinen O, Kauranen J, Tarkka E, Forsblom-Helander B, Grönroos JO, et al. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018. Eur J Clin Microbiol Infect Dis 2020;39:1651–6. DOI: 10.1007/s10096-020-03885-w.
  13. Otter JA, Mookerjee S, Davies F, Bolt F, Dyakova E, Shersing Y, et al. Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care. J Antimicrob Chemother 2020;75:2670–6. DOI: 10.1093/jac/dkaa192.
  14. Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA 2020;323:1478–87. DOI: 10.1001/jama.2020.2717.
  15. Campion M, Scully G. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation. J Intensive Care Med 2018;33:647–55. DOI: 10.1177/0885066618762747.
  16. Londero A, Costa M, Sucari A, Leotta G. Comparison of three molecular subtyping techniques for Listeria monocytogenes. Rev Argent Microbiol Argent J Microbiol 2019;51:359–62. DOI: 10.1016/j.ram.2019.01.003.
  17. Coșeriu RL, Vintilă C, Mare AD, Ciurea CN, Togănel RO, Cighir A, et al. Epidemiology, Evolution of Antimicrobial Profile and Genomic Fingerprints of Pseudomonas aeruginosa before and during COVID-19: Transition from Resistance to Susceptibility. Life 2022;12:2049. DOI: 10.3390/life12122049.
DOI: https://doi.org/10.2478/jccm-2025-0048 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 347 - 356
Submitted on: Jul 7, 2025
Accepted on: Oct 21, 2025
Published on: Oct 31, 2025
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Camelia Vintila, Razvan Lucian Coseriu, Alexandru Andrei Ujlaki Nagi, Adrian Man, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.